Adenoviral vector DNA for accurate genome editing with engineered nucleases

Nature Methods

Volumn 11, Issue 10, 2014, Pages 1051-1057

  Holkers, Maarten ^a   Maggio, Ignazio ^a   Henriques, Sara F D ^a,b   Janssen, Josephine M ^a   Cathomen, Toni ^c   Gonçalves, Manuel A F V ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LISBON   (Portugal)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; LENTIVIRUS VECTOR; NUCLEASE; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; VIRUS DNA; DEOXYRIBONUCLEASE; DNA;

ARTICLE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONTROLLED CLINICAL TRIAL (TOPIC); DNA CLEAVAGE; DNA INTEGRATION; DNA MODIFICATION; DNA REPAIR; DNA STRAND BREAKAGE; DNA STRUCTURE; DNA TEMPLATE; ENZYME ENGINEERING; FEMALE; GENE TARGETING; GENOMICS; HELA CELL LINE; HOMOLOGOUS RECOMBINATION; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRANSGENE; ADENOVIRIDAE; CELL LINE; CELL SEPARATION; CHEMISTRY; GENETIC ENGINEERING; GENETIC RECOMBINATION; GENETICS; GENOME; HEK293 CELL LINE; NUCLEOTIDE REPEAT; POLYMERASE CHAIN REACTION; PROCEDURES; REPRODUCIBILITY;

MAMMALIA;

ADENOVIRIDAE; CELL LINE; CELL SEPARATION; DEOXYRIBONUCLEASES; DNA; DNA, VIRAL; GENE TARGETING; GENETIC ENGINEERING; GENOME; HEK293 CELLS; HELA CELLS; HUMANS; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; REPETITIVE SEQUENCES, NUCLEIC ACID; REPRODUCIBILITY OF RESULTS;

EID: 84921779116     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth.3075     Document Type: Article

References (57)

1. Capecchi, M.R. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat. Rev. Genet. 6, 507-512 (2005).
2. Itzhaki, J.E. & Porter, A.C. Targeted disruption of a human interferon-inducible gene detected by secretion of human growth hormone. Nucleic Acids Res. 19, 3835-3842 (1991).
3. Brown, J.P., Wei, W. & Sedivy, J.M. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277, 831-834 (1997).
4. Russell, D.W. & Hirata, R.K. Human gene targeting by viral vectors. Nat. Genet. 18, 325-330 (1998).
5. Segal, D.J. & Meckler, J.F. Genome engineering at the dawn of the golden age. Annu. Rev. Genomics Hum. Genet. 14, 135-158 (2013).
6. Biasco, L., Baricordi, C. & Aiuti, A. Retroviral integrations in gene therapy trials. Mol. Ther. 20, 709-716 (2012).
7. Varga, C.M. et al. Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes. Gene Ther. 12, 1023-1032 (2005).
8. Wanisch, K. & Yáñez-Muñoz, R.J. Integration-deficient lentiviral vectors: A slow coming of age. Mol. Ther. 17, 1316-1332 (2009).
9. Cornu, T.I. & Cathomen, T. Targeted genome modifications using integrase-deficient lentiviral vectors. Mol. Ther. 15, 2107-2113 (2007).
10. Lombardo, A. et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 25, 1298-1306 (2007).
11. Gabriel, R. et al. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat. Biotechnol. 29, 816-823 (2011).
12. Lombardo, A. et al. Site-specific integration and tailoring of cassette design for sustainable gene transfer. Nat. Methods 8, 861-869 (2011).
13. Benabdallah, B.F. et al. Targeted gene addition of microdystrophin in mice skeletal muscle via human myoblast transplantation. Mol. Ther. Nucleic Acids 2, e68 (2013).
14. Coluccio, A. et al. Targeted gene addition in human epithelial stem cells by zinc-finger nuclease-mediated homologous recombination. Mol. Ther. 21, 1695-1704 (2013).
15. Mussolino, C. et al. TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity. Nucleic Acids Res. 42, 6762-6773 (2014).
16. Holkers, M. et al. Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res. 41, e63 (2013).
17. Nightingale, S.J. et al. Transient gene expression by nonintegrating lentiviral vectors. Mol. Ther. 13, 1121-1132 (2006).
18. Mátrai, J. et al. Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk. Hepatology 53, 1696-1707 (2011).
19. Miller, D.G., Petek, L.M. & Russell, D.W. Human gene targeting by adeno-associated virus vectors is enhanced by DNA double-strand breaks. Mol. Cell. Biol. 23, 3550-3557 (2003).
20. Li, H. et al. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 475, 217-221 (2011).
21. Ellis, B.L., Hirsch, M.L., Porter, S.N., Samulski, R.J. & Porteus, M.H. Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs. Gene Ther. 20, 35-42 (2013).
22. Rahman, S.H. et al. The nontoxic cell cycle modulator indirubin augments transduction of adeno-associated viral vectors and zinc-finger nuclease-mediated gene targeting. Hum. Gene Ther. 24, 67-77 (2013).
23. Miller, D.G., Petek, L.M. & Russell, D.W. Adeno-associated virus vectors integrate at chromosome breakage sites. Nat. Genet. 36, 767-773 (2004).
24. Gonçalves, M.A.F.V. & de Vries, A.A.F. Adenovirus: from foe to friend. Rev. Med. Virol. 16, 167-186 (2006).
25. Terns, R.M. & Terns, M.P. CRISPR-based technologies: prokaryotic defense weapons repurposed. Trends Genet. 30, 111-118 (2014).
26. Fu, Y. et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31, 822-826 (2013).
27. Hsu, P.D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827-832 (2013).
28. Cradick, T.J., Fine, E.J., Antico, C.J. & Bao, G. CRISPR/Cas9 systems targeting-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res. 41, 9584-9592 (2013).
29. Miller, D.G., Rutledge, E.A. & Russell, D.W. Chromosomal effects of adeno-associated virus vector integration. Nat. Genet. 30, 147-148 (2002).
30. Chadeuf, G., Ciron, C., Moullier, P. & Salvetti, A. Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery. Mol. Ther. 12, 744-753 (2005).
31. Miller, J.C. et al. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat. Biotechnol. 25, 778-785 (2007).
32. Szczepek, M. et al. Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nat. Biotechnol. 25, 786-793 (2007).
33. Doyon, Y. et al. Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat. Methods 8, 74-79 (2011).
34. Pattanayak, V., Ramirez, C.L., Joung, J.K. & Liu, D.R. Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat. Methods 8, 765-770 (2011).
35. Petek, L.M., Russell, D.W. & Miller, D.G. Frequent endonuclease cleavage at off-target locations in vivo. Mol. Ther. 18, 983-986 (2010).
36. Miller, D.G. et al. Large-scale analysis of adeno-associated virus vector integration sites in normal human cells. J. Virol. 79, 11434-11442 (2005).
37. Nakai, H. et al. Helper-independent and AAV-ITR-independent chromosomal integration of double-stranded linear DNA vectors in mice. Mol. Ther. 7, 101-111 (2003).
38. Choi, V.W., McCarty, D.M. & Samulski, R.J. Host cell DNA repair pathways in adeno-associated viral genome processing. J. Virol. 80, 10346-10356 (2006).
39. Duffy, S., Shackelton, L.A. & Holmes, E.C. Rates of evolutionary change in viruses: patterns and determinants. Nat. Rev. Genet. 9, 267-276 (2008).
40. Khan, I.F., Hirata, R.K. & Russell, D.W. AAV-mediated gene targeting methods for human cells. Nat. Protoc. 6, 482-501 (2011).
41. Gonçalves, M.A.F.V., van der Velde, I., Knaän-Shanzer, S., Valerio, D. & de Vries, A.A.F. Stable transduction of large DNA by high-capacity adeno-associated virus/adenovirus hybrid vectors. Virology 321, 287-296 (2004).
42. Fallaux, F.J. et al. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther. 9, 1909-1917 (1998).
43. Havenga, M.J. et al. Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivity. Biotechnol. Bioeng. 100, 273-283 (2008).
44. Cudré-Mauroux, C. et al. Lentivector-mediated transfer of Bmi-1 and telomerase in muscle satellite cells yields a Duchenne myoblast cell line with long-term genotypic and phenotypic stability. Hum. Gene Ther. 14, 1525-1533 (2003).
45. Gonçalves, M.A.F.V. et al. Transcription factor rational design improves directed differentiation of human mesenchymal stem cells into skeletal myocytes. Mol. Ther. 19, 1331-1341 (2011).
46. Janssen, J.M., Liu, J., Skokan, J., Gonçalves, M.A.F.V. & de Vries, A.A.F. Development of an AdEasy-based system to produce first-and second-generation adenoviral vectors with tropism for CAR-or CD46-positive cells. J. Gene Med. 15, 1-11 (2013).
47. Maggio, I. et al. Adenoviral vector delivery of RNA-guided CRISPR/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells. Sci. Rep 4, 5105 (2014).
48. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823-826 (2013).
49. Holkers, M., Cathomen, T. & Gonçalves, M.A.F.V. Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells. Methods doi:10.1016/j.ymeth.2014.02.017 (20 February 2014).
50. Pelascini, L.P.L. et al. Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zinc-finger nucleases. Hum. Gene Ther. Methods 24, 399-411 (2013).
51. Pelascini, L.P.L., Janssen, J.M. & Gonçalves, M.A.F.V. Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells. Hum. Gene Ther. 24, 78-96 (2013).
52. Pelascini, L.P.L. & Gonçalves, M.A.F.V. Lentiviral vectors encoding zinc-finger nucleases specific for the model target locus HPRT1. Methods Mol. Biol. 1114, 181-199 (2014).
53. Brielmeier, M. et al. Improving stable transfection efficiency: Antioxidants dramatically improve the outgrowth of clones under dominant marker selection. Nucleic Acids Res. 26, 2082-2085 (1998).
54. van Nierop, G.P., de Vries, A.A.F., Holkers, M., Vrijsen, K.R. & Gonçalves, M.A.F.V. Stimulation of homology-directed gene targeting at an endogenous human locus by a nicking endonuclease. Nucleic Acids Res. 37, 5725-5736 (2009).
55. Szuhai, K. & Tanke, H.J. COBRA: combined binary ratio labeling of nucleic-acid probes for multi-color fluorescence in situ hybridization karyotyping. Nat. Protoc. 1, 264-275 (2006).
56. Gonçalves, M.A.F.V. et al. Targeted chromosomal insertion of large DNA into the human genome by a fiber-modified high-capacity adenovirus-based vector system. PLoS ONE 3, e3084 (2008).
57. Holkers, M., de Vries, A.A.F. & Gonçalves, M.A.F.V. Nonspaced inverted DNA repeats are preferential targets for homology-directed gene repair in mammalian cells. Nucleic Acids Res. 40, 1984-1999 (2012).